Novel PEX3 Gene Mutations Resulting in a Moderate Zellweger Spectrum Disorder

C Maxit, I Denzler, D Marchione, G Agosta… - JIMD Reports, Volume …, 2017 - Springer
C Maxit, I Denzler, D Marchione, G Agosta, J Koster, RJA Wanders, S Ferdinandusse…
JIMD Reports, Volume 34, 2017Springer
Abstract Background: Peroxisome biogenesis disorders (PBDs) may have a variable clinical
expression, ranging from severe, lethal to mild phenotypes with progressive evolution. PBDs
are autosomal recessive disorders caused by mutations in PEX genes, which encode
proteins called peroxins, involved in the assembly of the peroxisome. Patient Description:
We herein report a patient who is currently 9 years old and who is compound heterozygous
for two novel mutations in the PEX3 gene. Results: Mild biochemical abnormalities of the …
Abstract
Background: Peroxisome biogenesis disorders (PBDs) may have a variable clinical expression, ranging from severe, lethal to mild phenotypes with progressive evolution. PBDs are autosomal recessive disorders caused by mutations in PEX genes, which encode proteins called peroxins, involved in the assembly of the peroxisome.
Patient Description: We herein report a patient who is currently 9 years old and who is compound heterozygous for two novel mutations in the PEX3 gene.
Results: Mild biochemical abnormalities of the peroxisomal parameters suggested a Zellweger spectrum defect in the patient. Sequence analysis of the PEX3 gene identified two novel heterozygous, pathogenic mutations.
Conclusion: Mutations in PEX3 usually result in a severe, early lethal phenotype. We report a patient compound heterozygous for two novel mutations in the PEX3 gene, who is less affected than previously reported patients with a defect in the PEX3 gene. Our findings indicate that PEX3 defects may cause a disease spectrum similar as previously observed for other PEX gene defects.
Springer